DANGERS of DENTAL ANESTHETICS (From Letters to the Editor, Issue #1 of Cavitations Plus Quarterly newsletter)
©2004 Suzin Stockton
Since this is our first edition of "Cavitations
Plus Quarterly," we have no actual "Letters
to the Editor" to reprint. However,
we do want to share two other bits of relevant
correspondence that should be of interest.
The first letter is one written by me (Suzin)
to "The Townsend Letter for Doctors
and Patients" and printed in the June,
1998, edition of that magazine.
Editor:
It came to my attention several months ago
that the breakdown products of many of the
local anesthetics commonly used in dentistry
are aggressively carcinogenic. This information
was passed on to me from folks involved in
the practice of biological dentistry who
were so strongly affected by the finding
they had uncovered that they greatly reduced
the use of aniline-based injectable anesthetics,
replacing them with intravenously administered
demerol in their practice.
The aniline-based anesthetics encompass the
"caine" family of anesthetics (lidocaine,
prilocaine, procaine, etc.). According to
Dr. Alfred Nickel ("Aniline-induced
Toxicities from Local Anesthetics,"
http://www.garynull.com/Article.aspx?Article=/Library.aspx&Head=Library),
"aniline compounds are well documented
human poisons, classic carcinogens and neurotoxins."
And, "The most effective route of delivery
is injection into the human bloodstream,"
for entering the body in this manner, they
escape both gastrointestinal absorption and
liver detoxification.
The Concise American Heritage Dictionary defines aniline as "a colorless, oily,
poisonous liquid" ... used to manufacture
various industrial products, including rubber,
resins and varnishes. Anilines belong to
the chemical family known as aromatic hydrocarbons.
Other members of this family include benzene,
phenol, hydroquinone, toluene, xylene and
napthalene. All have similar effects, described
by Dr. Stephen C. Byrnes ("Benzene and
AIDS," Townsend Letter for Doctors and Patients, 4/98), "They accumulate in and damage
the bone marrow, causing anemia and depressed
immune function." Dr. Byrnes goes on
to state that aniline is related to both
benzene and ammonia, and it is "used
to make a variety of organic chemical compounds,
including pharmaceuticals, photographic chemicals
and dye intermediaries." Tobacco and
pesticides also contain some anailine derivatives.
According to Dr. Nickel, bladder cancer among
aniline dye workers was described as early
as 1895 by a German doctor. Despite this
and other early (pre-1900) findings regarding
the health hazards of anilines, the use of
novacaine, developed in 1905, soon became
widespread. We now routinely use such aniline-based
local anesthetics in medicine and dentistry
with no thought to (or knowledge of) their
toxic properties. Why has the knowledge of
aniline-induced toxicity from local anesthetics
been overlooked? Could it have something
to do with the fact that annual sales of
these anesthetics amount to some $500,000,000.
in the U.S. alone?
Dr. Nickel tells us that "The theory
that the local anesthetic molecule is always
excreted from the body intact is unsupported
in the scientific literature" and is
based largely on "assurances of pharmaceutical
companies that manufacture local anesthetics..."
He goes on to cite evidence of the metabolic
conversion of aniline pharmaceuticals to
their aniline homologs. That evidence includes
a 1972 study wherein the aniline derivative,
2,6-dimethylaniline, was recovered from the
urine of animals who had been given lidocaine
orally, as well as human studies with similar
findings published in 1994. 2,6-dimethylaniline
is known to cross the blood-brain barrier
and to "alter gross neurological structure"
in animal studies, according to Nickel.
Since the effect of anilines is cumulative,
repetitive exposure to them, as one has when
undergoing prolonged, extensive medical or
dental treatment, can constitute a major,
overlooked cause of cancer and other serious
disorders. Although no formal studies have
established a link between cancer in humans
and exposure to local anesthetics, evidence
suggests a connection. Among the evidence
cited by Nickel is the following observation:
Our research team noted a curious and intriguing
commonality among the 30 cancer patients
evaluated at a recent meeting of the tumor
board of one of the local hospitals. Each
patient's dental history was visualized on
the total body scans (crowns, fillings, etc.
produce shadows on the film). The total body
scans clearly demonstrated that each of the
patients had undergone from 12 to 28 crown
and bridge dental procedures, necessitating
extensive exposure to local anesthetics.
The amount of aniline resulting from routine
clinical use of local anesthetics frequently
exceeds the maximum recommended in daily
occupational exposure (skin and lung exposure
of 10 and 20 mg. per cubic meter in short
and long-term exposure respectively). Only
1 cc of 2% lidocaine produces 10 mg. of 2,
6-dimethylaniline. A dentist may inject as
much as 14 cc of lidocaine when doing an
extraction. This amounts to 140 mg. of 2,
6 dimethylaniline. Considering that one unfiltered
cigarette contains 102 nanograms of 2,6-dimethylaniline,
"It would be necessary to smoke a pack
of unfiltered cigarettes a day for approximately
12.9 years to inhale an equivalent amount
of 2,6-dimethylaniline to that injected in
a single cc of 2% lidocaine," according
to Nickel.
Referencing two toxicological guides, The Hazardous Chemicals Desk Reference and The Handbook of Poisoning, Dr. Byrnes summarizes this information on
the effects of lidocaine:
...(Lidocaine is a ) poison by ingestion
and subcutaneous routes. Excitement, hallucinations,
distorted perceptions, changes in heart rate
and apnea. Anesthetic rapidly absorbed by
mucous methemoglobenemia.
Ingestion of anilines at levels greater than
1 gram can also cause headache, paresthesia,
hyperalgia, polyneuritis, dizziness, hypotension,
convulsion, muscle weakness and digestive
distress, according to Nickel who also cites
German literature which refers to development
of allergies and "other known neurotoxicities"
in human subjects from hyroxyaniline (breakdown
product of novacaine/procaine). A host of
other symptoms has been recorded in animal
studies.
In view of the suppressed information that
has now surfaced regarding aniline toxicity,
the widespread use of aniline-based local
anesthetics in medicine and dentistry should
be seriously reassessed.
|
suzin@healthcarealternatives.net
|
Information on this site is for educational purposes only and is not to be construed as medical advice. If you have a medical or dental condition, please consult an appropriate health care provider.